ArcticZymes Technologies Logo

ArcticZymes Technologies

AZT | BR

Overview

Corporate Details

ISIN(s):
NO0010014632
LEI:
5967007LIEEXZXGR7K47
Country:
Norway
Address:
FORSKNINGSPARKEN, 9019 TROMSØ
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and sale of novel recombinant enzymes. With over 30 years of focused expertise, the company develops unique, high-performance enzymes, often derived from Arctic marine organisms, that are engineered to function in challenging conditions such as high-salt and low-temperature environments. Its products are critical components for customers in the molecular research, diagnostics (MDx), therapeutics, and biopharmaceutical manufacturing sectors, with key applications in gene therapy, vaccine production, and DNA purification. The company provides customized enzymatic solutions through close collaboration with its clients to advance molecular science.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for ArcticZymes Technologies. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 18:00
Director's Dealing
ArcticZymes Technologies ASA - Mandatory notification of trades by close associ…
English 205.9 KB
2025-08-14 18:00
Director's Dealing
ArcticZymes Technologies ASA - Mandatory notification of trades by close associ…
English 945 bytes
2025-08-14 07:00
Quarterly Report
ArcticZymes Technologies Reports Q2 and H1 2025 Results: Biomanufacturing Growt…
English 1.8 MB
2025-08-14 07:00
Investor Presentation
ArcticZymes Technologies Reports Q2 and H1 2025 Results: Biomanufacturing Growt…
English 2.5 MB
2025-08-14 07:00
Earnings Release
ArcticZymes Technologies Reports Q2 and H1 2025 Results: Biomanufacturing Growt…
English 308.2 KB
2025-08-14 07:00
Earnings Release
ArcticZymes Technologies Reports Q2 and H1 2025 Results: Biomanufacturing Growt…
English 6.7 KB
2025-08-07 08:31
Report Publication Announcement
ArcticZymes Technologies ASA: Invitation to presentation of Q2 and 6M 2025 resu…
English 1.1 KB
2025-06-16 07:00
Regulatory News Service
ArcticZymes Technologies Launches GMP-Grade Nuclease for Next-Generation Viral …
English 115.9 KB
2025-06-16 07:00
Regulatory News Service
ArcticZymes Technologies Launches GMP-Grade Nuclease for Next-Generation Viral …
English 3.1 KB
2025-06-04 11:10
Investor Presentation
ArcticZymes Technologies to present at Handelsbanken Small & Mid Cap Seminar 20…
English 3.0 MB
2025-06-04 11:10
Report Publication Announcement
ArcticZymes Technologies to present at Handelsbanken Small & Mid Cap Seminar 20…
English 754 bytes
2025-06-04 07:00
Director's Dealing
ArcticZymes Technologies AS - Mandatory notification of trade - Attachment: Not…
English 117.8 KB
2025-06-04 07:00
Director's Dealing
ArcticZymes Technologies AS - Mandatory notification of trade
English 854 bytes
2025-05-28 13:32
Environmental & Social Information
ArcticZymes and Austrian Centre of Industrial Biotechnology Extend Collaborativ…
English 80.6 KB
2025-05-28 13:32
Regulatory News Service
ArcticZymes and Austrian Centre of Industrial Biotechnology Extend Collaborativ…
English 4.2 KB

Automate Your Workflow. Get a real-time feed of all ArcticZymes Technologies filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ArcticZymes Technologies via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK